Health & Personal Care
HIGH
FDA DRUG
Exela Pharma Sciences 4.2% Sodium Bicarbonate Injection Recalled Over Arsenic Impurity Out-Of-Spec
Exela Pharma Sciences recalls 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL, nationwide in the U.S. The recall cites out-of-spec arsenic impurities. Consumers should stop use and contact a healthcare provider. Follow recall notice for guidance and refunds.
SODIUM BICARBONATE
Failed Impurities/Degradation